Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV prevention policy news

Show

From To
Hysteria about drugs and harm minimisation. It's always the same old story

"No matter how impressive the evidence of benefits, or how weak the evidence of serious side effects or how badly a strategy is needed, new harm reduction strategies are always greeted the same way: with relentless hostility. Debates about harm reduction always follow the same pattern. Hysterical fears are confidently asserted as if proven beyond doubt while potential benefits, often based on considerable research and experience, are dismissed or ignored."

Published
23 August 2016
From
The Guardian
The end of the end of AIDS

The Durban 2016 AIDS Conference marks the end of "ending the HIV epidemic" as a feasible goal with the tools we have. We need new and better tools. Talk of ending AIDS has led to a widespread perception in the broader health and development community that this crisis is over. It isn't.

Published
16 August 2016
From
World Bank (blog)
As Trump Vice President, Mike Pence Would Be a Nightmare for People With HIV

There is nothing in Mike Pence's statements or actions to suggest that he has learned anything from the HIV outbreak that ran rampant through Scott County, Indiana, when he governed the state. As one indication of his HIV priorities, his advocacy for LGBT conversion therapy while in the U.S. House of Representatives included proposing that the Ryan White Care Act be reauthorized only if monies were redirected towards organizations "which provide assistance to those seeking to change their sexual behavior."

Published
15 August 2016
From
The Body
Why Doesn’t NHS England Want to Be Responsible for Preventing HIV?

In March 2015, Simon Stevens, Chief Executive of NHS England, announced the first national diabetes prevention programme. Reflecting on the potential for the NHS to reduce the future costs of diabetes care by supporting people to lose weight, exercise and eat better, he said that "if these results were from a pill we'd doubtless be popping it".

Published
11 August 2016
From
National AIDS Trust
New York's 'queer health warrior': city official funds grassroots fight against HIV

Demetre Daskalakis, the assistant health commissioner helming the HIV/Aids bureau, reaches out to the LGBT community to go beyond ending the epidemic.

Published
08 August 2016
From
The Guardian
HIV is back on the front pages

At The King's Fund, we have argued for empowering local services to reform from within rather than relying on top-down direction, regulation or market forces to deliver high-quality care. The dispute over the funding of antiretroviral drugs for prevention illustrates the challenges of doing this in the absence of an effective strategic and integrated approach to commissioning, especially when the structures are so complex and the relationship between local decisions and national strategy so loosely defined.

Published
03 August 2016
From
The King's Fund
Think the Aids epidemic is over? Far from it – it could be getting worse

The 2000 Aids conference in Durban shocked the world into action. Now, a new crisis looms, one fuelled by drug resistance, costly treatments and the lack of power many women have in sexual relationships.

Published
31 July 2016
From
The Guardian
Hope for 'end of Aids' is disappearing, experts warn

Those fighting epidemic say 2030 target is unrealistic as efforts to defeat it falter amid rising infection levels and drug resistance.

Published
31 July 2016
From
The Guardian
PrEP rollout recipients in France top 1000: full trial results report 97% effectiveness

Up to July 2016, 1077 people, 96.4% of them gay men, have started HIV pre-exposure prophylaxis (PrEP) through the public healthcare system in France, Jean-Michel Molina, principal

Published
29 July 2016
By
Gus Cairns
As EU Approval Moves Closer Are Governments Prepared For PrEP?

On Friday the EU's Committee for Medicinal Products for Human Use (CHMP) announced its positive opinion on Gilead’s HIV pre-exposure prophylaxis product Truvada PrEP. But with many European governments trying to control healthcare costs, the biggest issue facing Truvada PrEP might not be approval but rather reimbursement.

Published
27 July 2016
From
Seeking Alpha
← First12345...97Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close